Abound Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$2	–	1210
2023 Q1	$2	Buy	+1	New	+$2	﹤0.01%	721